Aprea Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aprea Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2024.
  • Aprea Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -56.4 %, a 2.08% decline year-over-year.
  • Aprea Therapeutics, Inc. annual Return On Equity for 2023 was -65.6 %, a 91.3% increase from 2022.
  • Aprea Therapeutics, Inc. annual Return On Equity for 2022 was -750 %, a 1077% decline from 2021.
  • Aprea Therapeutics, Inc. annual Return On Equity for 2021 was -63.7 %, a 13.2% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -56.4 -1.15 -2.08% Apr 1, 2024 Jun 30, 2024
Q1 2024 -56.8 +959 +94.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -65.6 +685 +91.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -55.5 +507 +90.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -55.2 +391 +87.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.02K -947 -1388% Jan 1, 2023 Mar 31, 2023
Q4 2022 -750 -686 -1077% Oct 1, 2022 Dec 31, 2022
Q3 2022 -562 -494 -719% Jul 1, 2022 Sep 30, 2022
Q2 2022 -446 -382 -594% Apr 1, 2022 Jun 30, 2022
Q1 2022 -68.2 -4.2 -6.56% Jan 1, 2022 Mar 31, 2022
Q4 2021 -63.7 -7.42 -13.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -68.6 -20.7 -43.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -64.3 +3.32 +4.91% Apr 1, 2021 Jun 30, 2021
Q1 2021 -64 +65.5 +50.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -56.3 -228 -133% Oct 1, 2020 Dec 31, 2020
Q3 2020 -48 Jul 1, 2020 Sep 30, 2020
Q2 2020 -67.6 Apr 1, 2020 Jun 30, 2020
Q1 2020 -130 Jan 1, 2020 Mar 31, 2020
Q4 2019 172 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.